 |
The Journal of Neuroscience, May 5, 2004, 24(18):4469-4477; doi:10.1523/JNEUROSCI.5560-03.2004
Previous Article | Next Article 
Neurobiology of Disease
Expression of a Poly-Glutamine-Ataxin-3 Transgene in Orexin Neurons Induces NarcolepsyCataplexy in the Rat
Carsten T. Beuckmann,1,2 *
Christopher M. Sinton,3 *
S. Clay Williams,1,2
James A. Richardson,4
Robert E. Hammer,1,5
Takeshi Sakurai,6,7 and
Masashi Yanagisawa1,2,7
1Howard Hughes Medical Institute, 2Department of Molecular Genetics, 3Department of Internal Medicine, 4Department of Pathology, 5Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, 6Department of Pharmacology, Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan, and 7 Exploratory Research for Advanced Technology Yanagisawa Orphan Receptor Project, Japan Science and Technology Agency, Tokyo 135-0064, Japan
The sleep disorder narcolepsy has been linked to loss of hypothalamic neurons producing the orexin (hypocretin) neuropeptides. Here, we report the generation of transgenic rats expressing a human ataxin-3 fragment with an elongated polyglutamyl stretch under control of the human prepro-orexin promoter (orexin/ataxin-3 rats). At 17 weeks of age, the transgenic rats exhibited postnatal loss of orexin-positive neurons in the lateral hypothalamus, and orexin-containing projections were essentially undetectable. The loss of orexin production resulted in the expression of a phenotype with fragmented vigilance states, a decreased latency to rapid eye movement (REM) sleep and increased REM sleep time during the dark active phase. Wakefulness time was also reduced during the dark phase, and this effect was concentrated at the photoperiod boundaries. Direct transitions from wakefulness to REM sleep, a defining characteristic of narcolepsy, occurred frequently. Brief episodes of muscle atonia and postural collapse resembling cataplexy were also noted while rats maintained the electroencephalographic characteristics of wakefulness. These findings indicate that the orexin/ataxin-3 transgenic rat could provide a useful model of human narcolepsy.
Key words: cataplexy; electroencephalography; electromyography; sleep; REM; lateral hypothalamus
Received Dec 17, 2003;
revised March 26, 2004;
accepted March 28, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
B. M. Kublaoui, T. Gemelli, K. P. Tolson, Y. Wang, and A. R. Zinn
Oxytocin Deficiency Mediates Hyperphagic Obesity of Sim1 Haploinsufficient Mice
Mol. Endocrinol.,
July 1, 2008;
22(7):
1723 - 1734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Diniz Behn, N. Kopell, E. N. Brown, T. Mochizuki, and T. E. Scammell
Delayed Orexin Signaling Consolidates Wakefulness and Sleep: Physiology and Modeling
J Neurophysiol,
June 1, 2008;
99(6):
3090 - 3103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Blanco-Centurion, D. Gerashchenko, and P. J. Shiromani
Effects of Saporin-Induced Lesions of Three Arousal Populations on Daily Levels of Sleep and Wake
J. Neurosci.,
December 19, 2007;
27(51):
14041 - 14048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Landry and R. E. Mistlberger
Food Entrainment: Methodological Issues
J Biol Rhythms,
December 1, 2007;
22(6):
484 - 487.
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zhang, J. M. Zeitzer, T. Sakurai, S. Nishino, and E. Mignot
Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy
J. Physiol.,
June 1, 2007;
581(2):
649 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Jessberger, K. Nakashima, G. D. Clemenson Jr, E. Mejia, E. Mathews, K. Ure, S. Ogawa, C. M. Sinton, F. H. Gage, and J. Hsieh
Epigenetic Modulation of Seizure-Induced Neurogenesis and Cognitive Decline
J. Neurosci.,
May 30, 2007;
27(22):
5967 - 5975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. M. Kublaoui, J. L. Holder Jr., T. Gemelli, and A. R. Zinn
Sim1 Haploinsufficiency Impairs Melanocortin-Mediated Anorexia and Activation of Paraventricular Nucleus Neurons
Mol. Endocrinol.,
October 1, 2006;
20(10):
2483 - 2492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Morton, N. I. Wood, M. H. Hastings, C. Hurelbrink, R. A. Barker, and E. S. Maywood
Disintegration of the Sleep-Wake Cycle and Circadian Timing in Huntington's Disease
J. Neurosci.,
January 5, 2005;
25(1):
157 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Petersen, J. Gil, M. L.C. Maat-Schieman, M. Bjorkqvist, H. Tanila, I. M. Araujo, R. Smith, N. Popovic, N. Wierup, P. Norlen, et al.
Orexin loss in Huntington's disease
Hum. Mol. Genet.,
January 1, 2005;
14(1):
39 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mieda, S. C. Williams, C. M. Sinton, J. A. Richardson, T. Sakurai, and M. Yanagisawa
Orexin Neurons Function in an Efferent Pathway of a Food-Entrainable Circadian Oscillator in Eliciting Food-Anticipatory Activity and Wakefulness
J. Neurosci.,
November 17, 2004;
24(46):
10493 - 10501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. John, M.-F. Wu, N. T Maidment, H. A Lam, L. N Boehmer, M. Patton, and J. M Siegel
Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers
J. Physiol.,
October 15, 2004;
560(2):
587 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. B. Lundkvist, K. Kristensson, and M. Bentivoglio
Why Trypanosomes Cause Sleeping Sickness
Physiology,
August 1, 2004;
19(4):
198 - 206.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|